Extrapontine central myelinolysis with extrapyramidal symptoms in a 14-year-old boy with COVID-19 disease-related PIMS-TS
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | Ceska a slovenska neurologie a neurochirurgie |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.prolekare.cz/en/journals/czech-and-slovak-neurology-and-neurosurgery/2022-6-10/extrapontine-central-myelinolysis-with-extrapyramidal-symptoms-in-a-14-year-old-boy-with-covid-19-disease-related-pims-ts-133187 |
| Doi | http://dx.doi.org/10.48095/cccsnn2022503 |
| Keywords | extrapontine central myelinolysis; extrapyramidal symptoms; COVID-19; PIMS-TS |
| Description | Coronavirus disease 2019 (COVID-19) has spread throughout the world following an outbreak in China in 2019. Severe acute respiratory syndrome coronavirus 2 (SARS- -CoV-2) primarily targets the respiratory system. In symptomatic patients, the most common symptoms are fever, cough, and headache. Severe forms can present with pneumonia, acute respiratory distress syndrome, acute cardiac dysfunction, and multiorgan failure. Most reports have indicated that adolescents and children follow a milder clinical course. Nevertheless, recent reports alerted the medical community to a pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS). Dia¬gnostic criteria and management of PIMS-TS are already relatively well defined. |